Skip to main content

RedHill Biopharma Ltd.

RDHL
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001553846

In the last 90 days, RedHill Biopharma Ltd. insiders filed 0 open-market purchases and 1 sale; 14 institutions reported holding it in 13F filings for Q2 2026, worth $270.0K in total; no superinvestor holds it.

Q3 2024 vs. Q2 2024

How the institutions holding RedHill Biopharma Ltd. changed between Q2 2024 and Q3 2024.

All holders in Q3 2024All holders in Q2 2024

13F holders of RDHL: Q2 2024 compared with Q3 2024
MeasureQ2 2024Q3 2024Change
Holders1811−7
Shares1.94M5.59K−1.94M (−99.7%)
Value$719.7K$48.8K−$671.0K (−93.2%)

New holders (3)

Institutions that held RedHill Biopharma Ltd. at the end of Q3 2024 but not at the end of Q2 2024.

Institutions new to RDHL in Q3 2024
InstitutionSharesValue% of portfolio
Advisor Group Holdings, Inc.396$3.46K0.00%
Capital Performance Advisors LLP5$440.00%
Danske Bank A/S2$170.00%

Sold out (10)

Institutions that held RedHill Biopharma Ltd. at the end of Q2 2024 and filed for Q3 2024 without it.

Institutions that sold out of RDHL in Q3 2024
InstitutionShares, Q2 2024Value, Q2 2024
Sabby Management, LLC1,341,189$497.2K
Gagnon Securities LLC116,020$43.0K
Citadel Advisors LLC108,570$40.2K
Jane Street Group, LLC47,141$17.3K
Virtu Financial LLC37,114$14.0K
We Are One Seven, LLC15,750$5.84K
Two Sigma Securities, LLC13,028$4.83K
Flputnam Investment Management Co93$34
Wells Fargo & Company23$9
JPMorgan Chase & Co11$4